Cargando…
Hydrophilic High Drug-Loaded 3D Printed Gastroretentive System with Robust Release Kinetics
Three-dimensional printing (3DP) technology enables an important improvement in the design of new drug delivery systems, such as gastroretentive floating tablets. These systems show a better temporal and spatial control of the drug release and can be customized based on individual therapeutic needs....
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057139/ https://www.ncbi.nlm.nih.gov/pubmed/36986703 http://dx.doi.org/10.3390/pharmaceutics15030842 |
_version_ | 1785016288933838848 |
---|---|
author | Mora-Castaño, Gloria Millán-Jiménez, Mónica Caraballo, Isidoro |
author_facet | Mora-Castaño, Gloria Millán-Jiménez, Mónica Caraballo, Isidoro |
author_sort | Mora-Castaño, Gloria |
collection | PubMed |
description | Three-dimensional printing (3DP) technology enables an important improvement in the design of new drug delivery systems, such as gastroretentive floating tablets. These systems show a better temporal and spatial control of the drug release and can be customized based on individual therapeutic needs. The aim of this work was to prepare 3DP gastroretentive floating tablets designed to provide a controlled release of the API. Metformin was used as a non-molten model drug and hydroxypropylmethyl cellulose with null or negligible toxicity was the main carrier. High drug loads were assayed. Another objective was to maintain the release kinetics as robust as possible when varying drug doses from one patient to another. Floating tablets using 10–50% w/w drug-loaded filaments were obtained by Fused Deposition Modelling (FDM) 3DP. The sealing layers of our design allowed successful buoyancy of the systems and sustained drug release for more than 8 h. Moreover, the effect of different variables on the drug release behaviour was studied. It should be highlighted that the robustness of the release kinetics was affected by varying the internal mesh size, and therefore the drug load. This could represent a step forward in the personalization of the treatments, a key advantage of 3DP technology in the pharmaceutical field. |
format | Online Article Text |
id | pubmed-10057139 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100571392023-03-30 Hydrophilic High Drug-Loaded 3D Printed Gastroretentive System with Robust Release Kinetics Mora-Castaño, Gloria Millán-Jiménez, Mónica Caraballo, Isidoro Pharmaceutics Article Three-dimensional printing (3DP) technology enables an important improvement in the design of new drug delivery systems, such as gastroretentive floating tablets. These systems show a better temporal and spatial control of the drug release and can be customized based on individual therapeutic needs. The aim of this work was to prepare 3DP gastroretentive floating tablets designed to provide a controlled release of the API. Metformin was used as a non-molten model drug and hydroxypropylmethyl cellulose with null or negligible toxicity was the main carrier. High drug loads were assayed. Another objective was to maintain the release kinetics as robust as possible when varying drug doses from one patient to another. Floating tablets using 10–50% w/w drug-loaded filaments were obtained by Fused Deposition Modelling (FDM) 3DP. The sealing layers of our design allowed successful buoyancy of the systems and sustained drug release for more than 8 h. Moreover, the effect of different variables on the drug release behaviour was studied. It should be highlighted that the robustness of the release kinetics was affected by varying the internal mesh size, and therefore the drug load. This could represent a step forward in the personalization of the treatments, a key advantage of 3DP technology in the pharmaceutical field. MDPI 2023-03-04 /pmc/articles/PMC10057139/ /pubmed/36986703 http://dx.doi.org/10.3390/pharmaceutics15030842 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mora-Castaño, Gloria Millán-Jiménez, Mónica Caraballo, Isidoro Hydrophilic High Drug-Loaded 3D Printed Gastroretentive System with Robust Release Kinetics |
title | Hydrophilic High Drug-Loaded 3D Printed Gastroretentive System with Robust Release Kinetics |
title_full | Hydrophilic High Drug-Loaded 3D Printed Gastroretentive System with Robust Release Kinetics |
title_fullStr | Hydrophilic High Drug-Loaded 3D Printed Gastroretentive System with Robust Release Kinetics |
title_full_unstemmed | Hydrophilic High Drug-Loaded 3D Printed Gastroretentive System with Robust Release Kinetics |
title_short | Hydrophilic High Drug-Loaded 3D Printed Gastroretentive System with Robust Release Kinetics |
title_sort | hydrophilic high drug-loaded 3d printed gastroretentive system with robust release kinetics |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057139/ https://www.ncbi.nlm.nih.gov/pubmed/36986703 http://dx.doi.org/10.3390/pharmaceutics15030842 |
work_keys_str_mv | AT moracastanogloria hydrophilichighdrugloaded3dprintedgastroretentivesystemwithrobustreleasekinetics AT millanjimenezmonica hydrophilichighdrugloaded3dprintedgastroretentivesystemwithrobustreleasekinetics AT caraballoisidoro hydrophilichighdrugloaded3dprintedgastroretentivesystemwithrobustreleasekinetics |